CNSY

Cerenome, Inc.

$1.93

0.13 (6.53%) Today

0.07 (3.76%) After-hours

— up— down

Compare CNSY

Open

$1.86

Previous Close

$1.99

Day Range

$1.86 – $2.11

52-Week Range

$1.86 – $23.50

Volume

235.69K

Exchange

NasdaqCM

About CNSY

Cerenome, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system (CNS) cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Cerenome also commercialized a molecular diagnostic service, CNSide®.